Vendis Capital partners with BitterLiebe, a leading health supplements brand, to accelerate its growth and expand internationally within the gastrointestinal health market.
Target Information
BitterLiebe, headquartered in Mannheim, Germany, is a prominent direct-to-consumer brand specializing in premium health supplements aimed at gastrointestinal health. Founded in 2018 by Andre Sierek and Jan Stratmann, the brand leverages natural bitter substances as core ingredients to meet the rising consumer demand for gut health solutions. Since its inception, BitterLiebe has witnessed substantial growth fueled by innovative product offerings and a multifaceted distribution approach. The brand has been supported by ARCUS Capital, a family equity investor based in Munich, since 2020, and utilized the expertise of Start Now Consulting GmbH led by Judith Williams from its early days.
The company's diverse product range includes bitter drops, sprays, capsules, and powders, which are supplemented by probiotics and natural vitamins and minerals. BitterLiebe has developed a robust knowledge platform focusing on gastrointestinal health, fostering strong customer loyalty and attracting new clients. Initially successful with its e-commerce platform, BitterLiebe has expanded its reach to more than 6,000 offline sales points across drugstores and food retailers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The dietary supplement industry in Germany has experienced significant growth, propelled by an increasing awareness of health and wellness among consumers. The market is characterized by a shift towards natural products, with more individuals seek
Similar Deals
Q·CAPITAL VENTURES → fresh five* premiumfood Ltd.
2023
QC·VENTURES → fresh five* premiumfood GmbH
2023
European Circular Bioeconomy Fund → Prolupin
2023
Odewald KMU → Karl Schmidt GmbH
2023
Project A → WindStar Medical
2020
Vendis Capital
invested in
BitterLiebe
in 2023
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $320M